In contrast, participants with RA on JAK inhibitors had lower spike-specific CD4+ Th2 and Th17 cell numbers (cells per mL of whole blood) than controls but did not display higher numbers of spike-specific Tregs (Supplemental Fig. 3a–d). This evidence concerns the gene CD4 and rheumatoid arthritis.